BamSEC and AlphaSense Join Forces
Learn More

Prothena Corporation plc – Material Contracts

NASDAQ: PRTA    
Share price (6/3/26): $8.92    
Market cap (6/3/26): $467 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.9(B)
from 10-K 6 pages First Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan
12/34/56
EX-10.4(B)
from 10-K 4 pages Amendment Number One to Global License Agreement
12/34/56
EX-10.2
from 10-Q 13 pages Form of Restricted Share Unit Award Agreement Between Prothena Corporation plc and Registrant’s Named Executive Officers Prothena Corporation plc 2018 Long Term Incentive Plan Restricted Share Unit Award Agreement – Cover Sheet
12/34/56
EX-10.1
from 8-K 20 pages Form of Employment Agreement
12/34/56
EX-10.1
from 8-K 1 page Sixth Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan
12/34/56
EX-10.11(B)
from 10-K 5 pages First Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan
12/34/56
EX-10.2
from 10-Q 2 pages Chad J. Swanson, PH.D. September 27, 2024
12/34/56
EX-10.1
from 10-Q 9 pages Consulting Agreement
12/34/56
EX-10.3
from 10-Q 109 pages Global License Agreement
12/34/56
EX-10.1
from 8-K 1 page Fifth Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan
12/34/56
EX-10.2
from 10-Q 10 pages Sent by Email as Pdf January 16, 2024 Prothena Biosciences Limited 77 Sir John Rogerson’s Quay, Block C Grand Canal Docklands, Dublin 2, D02 Vk60, Ireland Attn: Company Secretary Re: [***] Dear Ms. Yvonne Tchrakian
12/34/56
EX-10.1
from 10-Q 3 pages David Ford February 12, 2024
12/34/56
EX-10.23
from 10-K 14 pages First Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan
12/34/56
EX-10.2
from 10-Q 77 pages Global License Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 1 page Fourth Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan
12/34/56
EX-10.1
from 10-Q 1 page Fourteenth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan
12/34/56
EX-10.22
from 10-K 13 pages First Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan
12/34/56
EX-10.15(B)
from 10-K 8 pages Consent to Sublease Agreement
12/34/56
EX-10.15(A)
from 10-K 17 pages This Sublease (This “Sublease”) Is Dated for Reference Purposes as of October 28, 2022 (The “Effective Date”), and Is Made by and Between Arcus Biosciences, Inc., a Delaware Corporation (“Sublessor”), and Prothena Biosciences Inc, a Delaware Corporation (“Sublessee”). Sublessor and Sublessee Hereby Agree as Follows
12/34/56